Bromodeoxyuridine (BrdU) is a synthetic nucleoside analogue of thymidine which can be incorporated into DNA in proliferating cells. During mitosis, BrdU may be incorporated into the newly synthezised DNA of S-phase cells, and can therefore provide an estimate for the fraction of cells in S-phase. Labeling cells with BrdU and then screening with BrdU antibodies has become a powerful tool to study the cytokinetics of normal and neoplastic cells. In vivo, BrdU is considered a potential carcinogen, as its incorporation into DNA may cause mutations.
Bioinformatics
Alternate Names
Bromodeoxyuridine
BUdr
Research Areas for Bromodeoxyuridine/BrdU
Find related products by research area and learn more about each of the different research areas below.
![Immunocytochemistry Bromodeoxyuridine/BrdU Antibody (BU-1) [Unconjugated]](http://images.novusbio.com/fullsize2/Bromodeoxyuridine_MAB7225_Immunocytochemistry_11780.jpg)
![Immunohistochemistry Bromodeoxyuridine/BrdU Antibody (BU-1) [Unconjugated]](http://images.novusbio.com/fullsize2/mab7225_bromodeoxyuridine-brdu-mab-clone-bu-1-immunohistochemistry-1062021113655.jpg)
![Immunohistochemistry Bromodeoxyuridine/BrdU Antibody (BU-1) [Unconjugated]](http://images.novusbio.com/fullsize2/mab7225_bromodeoxyuridine-brdu-mab-clone-bu-1-immunohistochemistry-106202111393.jpg)
![Intracellular Staining by Flow Cytometry Bromodeoxyuridine/BrdU Antibody (BU-1) [Unconjugated]](http://images.novusbio.com/fullsize2/Bromodeoxyuridine_MAB7225_Flow_Cytometry_11764.jpg)
